Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial.
Ontology highlight
SUBMITTER: Cameron D
PROVIDER: S-EPMC5489700 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA